Chloramphenicol disposition in infants and children

Area of Science:

• Pharmacology
• Pediatric Medicine
• Drug Metabolism

Background:

• Chloramphenicol is an antibiotic used to treat serious infections.
• Its pharmacokinetics in pediatric populations can vary significantly.
• Understanding drug clearance is crucial for safe and effective pediatric treatment.

Purpose of the Study:

• To investigate the pharmacokinetics of chloramphenicol sodium succinate in infants and children.
• To identify factors influencing chloramphenicol clearance and half-life.
• To assess the relationship between serum and cerebrospinal fluid (CSF) concentrations.

Main Methods:

• Intravenous administration of chloramphenicol sodium succinate to 54 pediatric patients.
• Measurement of plasma concentrations and calculation of elimination half-life (t 1/2).
• Analysis of chloramphenicol and related compounds, and CSF concentrations.

Main Results:

• Mean chloramphenicol elimination half-life was 5.94 hours, with wide individual variation.
• Patients weighing <10 kg had significantly longer half-lives (9.02 hours) than those weighing >10 kg (4.55 hours).
• CSF concentrations were 67% of serum concentrations; clearance rates of related compounds varied.

Conclusions:

• Significant inter-individual variability in chloramphenicol pharmacokinetics necessitates therapeutic drug monitoring in pediatric patients.
• Weight is a key factor influencing chloramphenicol half-life in children.
• Monitoring blood concentrations is essential for optimizing chloramphenicol therapy in infants and children.